Sign Up to like & get
recommendations!
1
Published in 2019 at "Cytokine"
DOI: 10.1016/j.cyto.2019.154873
Abstract: Type 1 reactions (T1R) an inflammatory condition, of local skin patches in 30-40% leprosy patients during the course of MDT. IL-17A and IL-17F play an important role in regulating skin inflammation through neutrophils. In the…
read more here.
Keywords:
17a 17f;
leprosy patients;
double positive;
producing neutrophils ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Nature Reviews Rheumatology"
DOI: 10.1038/s41584-018-0044-2
Abstract: Spondyloarthritis (SpA) is a term that refers to a group of inflammatory diseases that includes psoriatic arthritis, axial SpA and nonradiographic axial SpA, reactive arthritis, enteropathic arthritis and undifferentiated SpA. The disease subtypes share clinical…
read more here.
Keywords:
17a 17f;
immunopathology;
spondyloarthritis;
arthritis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Immunogenetics"
DOI: 10.1111/iji.12616
Abstract: Thank you for your comment on the publication ‘Associations between interleukin 17A and 17F polymorphisms and asthma susceptibility: A meta-analysis’ (Lee & Song, 2023). Your suggestion to focus on the effects of unexpected and potentially…
read more here.
Keywords:
meta analysis;
17a 17f;
17f polymorphisms;
research ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.1240
Abstract: Guselkumab (GUS), an IL-23 inhibitor monoclonal antibody (Mab) that specifically binds to the IL-23p19 subunit, demonstrated efficacy compared to placebo (PBO) in reducing skin and musculoskeletal signs and symptoms in patients (pts) with active psoriatic…
read more here.
Keywords:
janssen research;
effector cytokines;
17a 17f;
employee janssen ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "RMD Open"
DOI: 10.1136/rmdopen-2021-001679
Abstract: Objective To investigate serum protein expression in participants with psoriatic arthritis (PsA) and changes after guselkumab treatment. Methods Participants with PsA were treated with guselkumab or placebo in the DISCOVER-1 and DISCOVER-2 studies. Serum levels…
read more here.
Keywords:
acute phase;
17a 17f;
treatment;
effector cytokines ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/20406223211037846
Abstract: Psoriasis and psoriatic arthritis are chronic immune-mediated disorders with involvement of interleukin (IL)-17 cytokines in their pathogenesis. IL-17A has been considered to be the most biologically active, but IL-17F is also over-expressed in skin and…
read more here.
Keywords:
17a 17f;
inhibition 17a;
disease;
dual inhibition ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.653611
Abstract: Ankylosing spondylitis (AS) is a chronic autoimmune inflammatory disease that mainly affects the axial and sacroiliac joints. Single-nucleotide polymorphisms (SNPs) in genes encoding cytokines have been associated with AS, which can interfere with the production…
read more here.
Keywords:
17a 17f;
il10;
rs1800896;
serum ... See more keywords